Results 191 to 200 of about 71,029 (345)

CCN3, A NOVEL PRO-APOPTOTIC FACTOR FOR CHRONIC MYELOID LEUKAEMIA

, 2009
Lynn McCallum, Wanhua Lu, Susan Price, Nathalie Planque, Bernard Perbal, Nóra G. Lázár, Alexandra E. Irvine   +6 more
openalex   +1 more source

Most costly and prevalent reasons for hospitalization in children with medical complexity in Ontario, Canada

Journal of Hospital Medicine, EarlyView.
Abstract Background and Objectives Children with medical complexity (CMC) have chronic health conditions often associated with functional limitations. CMC comprise 1%–5% of the pediatric population. In Canada, their care accounts for one‐third of pediatric health spending.
Erin Hessey, Thaksha Thavam, Sanjay Mahant, Eyal Cohen, Jingqin Zhu, Francine Buchanan, Teresa To, Peter J. Gill, Ontario Pediatric Hospital Care Study Group (OPHCSG) and the Canadian Paediatric Inpatient Research Network (PIRN), Wenjia Chen, Ronald Cohn, Mairead Green, Matt Hall, Kate Langrish, Colin Macarthur, Myla Moretti, Patricia Parkin, Michelle Quinlan, Ann Bayliss, Ronik Kanani, Sean Murray, Catherine Pound, Mahmoud Sakran, Anupam Sehgal, Sepi Taheri, Gita Wahi   +25 more
wiley   +1 more source

Cytogenetic profile of chronic myeloid leukaemia patients resistant to imatinib at tertiary level in Indonesia. [PDF]

Mol Cytogenet
Rinaldi I, Louisa M, Arwanih EY, Adibah FF, Kadharusman MM, Remifta Putra MA, Winston K, Shufiyani YM, Salma RA.   +8 more
europepmc   +1 more source

Myeloid Sarcoma Masquerading as a Breast Lump: A Unique Presentation of Chronic Myeloid Leukaemia in Chronic Phase

openalex   +2 more sources

Artificial intelligence strategies for predicting kinase inhibitor resistance: A comprehensive review of methods, challenges, and future perspectives

Journal of Intelligent Medicine, EarlyView.
Abstract Kinase inhibitors are essential in targeted cancer therapy, yet resistance often emerges through secondary mutations, activation of compensatory signaling pathways, or drug‐efflux mechanisms. Artificial intelligence (AI) provides a workflow‐based strategy rather than a list of unrelated tools for predicting and addressing kinase‐inhibitor ...
Faris Hassan, Mohanad Ali Deifallah, Alaa Zaghloul, Rania Elgohary   +3 more
wiley   +1 more source

Two ophthalmic presentations of chronic myeloid leukaemia

eJHaem, 2022
Miles Kiernan, Hanna Renshaw, Danny Mitry, Fion Bremner   +3 more
doaj   +1 more source

Empirical and projected economic burden of chronic myeloid leukaemia in Sweden from 2015 to 2030: A population-based study. [PDF]

Br J Haematol
Chen EY, Dickman PW, Di Mari F, Dahlén T, Stenke L, Björkholm M, Clements MS, Hao S.   +7 more
europepmc   +1 more source

Donor cell acute myeloid leukaemia after haematopoietic stem cell transplantation for chronic granulomatous disease [PDF]

, 2023
Roberto Valli, Annalisa Frattini, Anna Leszl, Marco Zecca, Pamela Roccia, Paolo Bernasconi, Irene Dambruoso, Antonella Minelli, Giuseppe Montalbano, Giovanni Micheloni, Giovanni Porta, Francesco Pasquali   +11 more
openalex  

Epigenetic inflammatory memory and periodontal disease: Mechanisms and clinical significance for comorbidities

Journal of Periodontology, EarlyView.
Abstract Historically, immunological memory was considered an exclusive feature of adaptive immunity. However, innate immune cells have recently been shown to record and maintain epigenetically imprinted memory of earlier infectious or inflammatory challenges.
George Hajishengallis
wiley   +1 more source

Prognostic scoring systems in chronic myeloid leukaemia. [PDF]

Leukemia
Lauseker M, Hoffmann VS, Pfirrmann M.
europepmc   +1 more source